BIOMAT Database Logo BIOMAT Database Logo

Mapping the heparin-binding site on the 13-14F3 fragment of fibronectin. 2002

Sachchidanand, and Olivier Lequin, and David Staunton, and Barbara Mulloy, and Mark J Forster, and Keiichi Yoshida, and Iain D Campbell
Department of Biochemistry and Oxford Centre for Molecular Sciences, University of Oxford, South Parks Rd., Oxford OX1 3QU, United Kingdom.

Fibronectin, a multifunctional glycoprotein of the extracellular matrix, plays a major role in cell adhesion. Various studies have revealed that the human 13th and 14th fibronectin type III domains (labeled (13)F3 and (14)F3 here) contain a heparin-binding site. Mapping of the heparin-binding sites of (13-14)F3, (13)F3, and (14)F3 by NMR chemical shift perturbation, isothermal titration calorimetry, and molecular modeling show that (13)F3 provides the dominant heparin-binding site and that the residues involved are within the first 29 amino acids of (13)F3. Predictions from earlier biochemical and modeling studies as well as the x-ray structure of (12-14)F3 were tested. It was shown that the positively charged residues that project into the solvent from the ABE face of the triple-stranded beta sheet on (13)F3 are involved in binding, but (14)F3 does not appear to contribute significantly to heparin binding.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D009844 Oligosaccharides Carbohydrates consisting of between two (DISACCHARIDES) and ten MONOSACCHARIDES connected by either an alpha- or beta-glycosidic link. They are found throughout nature in both the free and bound form. Oligosaccharide
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D005353 Fibronectins Glycoproteins found on the surfaces of cells, particularly in fibrillar structures. The proteins are lost or reduced when these cells undergo viral or chemical transformation. They are highly susceptible to proteolysis and are substrates for activated blood coagulation factor VIII. The forms present in plasma are called cold-insoluble globulins. Cold-Insoluble Globulins,LETS Proteins,Fibronectin,Opsonic Glycoprotein,Opsonic alpha(2)SB Glycoprotein,alpha 2-Surface Binding Glycoprotein,Cold Insoluble Globulins,Globulins, Cold-Insoluble,Glycoprotein, Opsonic,Proteins, LETS,alpha 2 Surface Binding Glycoprotein
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin

Related Publications

Sachchidanand, and Olivier Lequin, and David Staunton, and Barbara Mulloy, and Mark J Forster, and Keiichi Yoshida, and Iain D Campbell
Localization of the major heparin-binding site in fibronectin.
April 1991, The Journal of biological chemistry,
Sachchidanand, and Olivier Lequin, and David Staunton, and Barbara Mulloy, and Mark J Forster, and Keiichi Yoshida, and Iain D Campbell
Mapping the heparin-binding site of mucus proteinase inhibitor.
February 1995, Biochemistry,
Sachchidanand, and Olivier Lequin, and David Staunton, and Barbara Mulloy, and Mark J Forster, and Keiichi Yoshida, and Iain D Campbell
Isolation of a tryptic fragment containing the collagen-binding site of plasma fibronectin.
July 1979, The Journal of biological chemistry,
Sachchidanand, and Olivier Lequin, and David Staunton, and Barbara Mulloy, and Mark J Forster, and Keiichi Yoshida, and Iain D Campbell
Mapping of three major heparin-binding sites on laminin and identification of a novel heparin-binding site on the B1 chain.
October 1989, The Journal of biological chemistry,
Sachchidanand, and Olivier Lequin, and David Staunton, and Barbara Mulloy, and Mark J Forster, and Keiichi Yoshida, and Iain D Campbell
Imaging and mapping heparin-binding sites on single fibronectin molecules with atomic force microscopy.
March 2000, Biochemistry,
Sachchidanand, and Olivier Lequin, and David Staunton, and Barbara Mulloy, and Mark J Forster, and Keiichi Yoshida, and Iain D Campbell
Mapping the heparin-binding site of the osteoinductive protein NELL1 by site-directed mutagenesis.
December 2015, FEBS letters,
Sachchidanand, and Olivier Lequin, and David Staunton, and Barbara Mulloy, and Mark J Forster, and Keiichi Yoshida, and Iain D Campbell
Identification of the anti-adhesive site buried within the heparin-binding domain of fibronectin.
February 1997, Journal of biochemistry,
Sachchidanand, and Olivier Lequin, and David Staunton, and Barbara Mulloy, and Mark J Forster, and Keiichi Yoshida, and Iain D Campbell
RGD-independent cell adhesion to the carboxy-terminal heparin-binding fragment of fibronectin involves heparin-dependent and -independent activities.
March 1990, The Journal of cell biology,
Sachchidanand, and Olivier Lequin, and David Staunton, and Barbara Mulloy, and Mark J Forster, and Keiichi Yoshida, and Iain D Campbell
Mapping a heparin binding site on ErbB-3 epidermal growth factor receptor.
April 2001, Biochemical and biophysical research communications,
Sachchidanand, and Olivier Lequin, and David Staunton, and Barbara Mulloy, and Mark J Forster, and Keiichi Yoshida, and Iain D Campbell
Fibronectin fibrillogenesis involves the heparin II binding domain of fibronectin.
January 1998, The Journal of biological chemistry,
Copied contents to your clipboard!